European biotech flourishes as US and Asian capital pours in
Despite benefiting from five times less investment compared with the US, the European biotech sector has blossomed in recent years, attracting increasing financing from a diversified mix of investors and producing several healthcare unicorns. Alessia Argentieri reports
More on Investments
Software sector lures increasing amounts of capital in CEE
Interest in the software sector in CEE is on the up and was especially prominent in Q3
Minority investing gains traction in southern Europe
Abundance of dry powder and expected downturn have pushed GPs towards experimenting with more diversified ways of deploying capital
Unquote Private Equity Podcast: Taking stock
Listen to the latest episode of the Unquote Private Equity Podcast, dedicated to the resurgence of take-privates
UK-focused GPs getting creative with buyout sourcing
In 2019, 10 take-privates have been agreed in the UK and Ireland to date, up from five in 2018
Latest News
Riverside carves out HealthTech BioActives from Ferrer
Deal includes three manufacturing facilities located in Spain, which employ around 140 staff
Capvis buys Tertianum Group
GP acquired the care home group from Swiss Prime Site and will be the company's sole shareholder
Iris Capital, Idinvest et al. inject $12.3m into Yubo
Iris, Idinvest and historical backers invest in the manager of the eponymous social media app
Mérieux Equity Partners backs Addmedica
GP uses its Mérieux Participations 3 fund, which held a first close on €200m in 2018